NVLX Translational Drug Development or TD2 will co
Post# of 1086
Posted On: 04/03/2014 2:04:45 PM
NVLX Translational Drug Development or TD2 will conduct preclinical and clinical studies for Nuvilex that seem aimed at the overall management of pancreatic cancer (further explanation below)
http: //finance.yahoo.com/news/nuvilex-investors-read-between-lines-130000508.html
http: //finance.yahoo.com/news/nuvilex-investors-read-between-lines-130000508.html
(0)
(0)PharmaCyte Biotech Inc. (PMCB) Stock Research Links
Scroll down for more posts ▼